These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 6539428)
21. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414 [TBL] [Abstract][Full Text] [Related]
22. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats. Chen YF; Oparil S Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797 [TBL] [Abstract][Full Text] [Related]
23. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
24. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat]. Jiang DH Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909 [No Abstract] [Full Text] [Related]
25. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
26. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites. Wong DT; Threlkeld PG; Bymaster FP Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223 [TBL] [Abstract][Full Text] [Related]
28. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats. Altar CA; O'Neil S; Marshall JF Neuropharmacology; 1984 Mar; 23(3):309-18. PubMed ID: 6427648 [TBL] [Abstract][Full Text] [Related]
29. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment. Honkanen A; Piepponen TP; Ahtee L Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562 [TBL] [Abstract][Full Text] [Related]
30. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related]
31. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation. Conway PG; Uretsky NJ J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019 [No Abstract] [Full Text] [Related]
32. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs. Magnusson O; Fowler CJ; Köhler C; Ogren SO Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362 [TBL] [Abstract][Full Text] [Related]
33. Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain. Wong DT; Bymaster FP; Reid LR; Fuller RW; Perry KW; Kornfeld EC J Neural Transm; 1983; 58(1-2):55-67. PubMed ID: 6655467 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine. Toru M; Mataga N; Takashima M; Nishikawa T Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423 [TBL] [Abstract][Full Text] [Related]
36. The pharmacology of Parkinson's disease: basic aspects and recent advances. Da Prada M; Keller HH; Pieri L; Kettler R; Haefely WE Experientia; 1984 Nov; 40(11):1165-72. PubMed ID: 6437857 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of gonadal steroids on dopamine metabolism in mesolimbic and nigro-striatal pathways of male rat brain. Alderson LM; Baum MJ Brain Res; 1981 Aug; 218(1-2):189-206. PubMed ID: 7272735 [TBL] [Abstract][Full Text] [Related]
38. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Hefti F; Melamed E; Wurtman RJ Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003 [TBL] [Abstract][Full Text] [Related]
39. Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease. Nakazato T; Akiyama A Brain Res; 2002 Mar; 930(1-2):134-42. PubMed ID: 11879803 [TBL] [Abstract][Full Text] [Related]
40. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]